Tag: PE

Thromboprophylaxis with anticoagulants “likely effective” at preventing VTE post-vascular surgery, larger...

“Among patients undergoing vascular surgery, thromboprophylaxis with anticoagulants showed a trend towards reduced incidence of VTE when compared to placebo,” Tarek Haykal (Duke...

Viz.ai and Avicenna.AI partner to launch AI-driven intelligent care coordination for...

Viz.ai has partnered with Avicenna.AI to enable intelligent care coordination and improve patient triage of patients suffering from pulmonary embolism (PE) and aortic disease. Avicenna.AI’s US...
Thrombolex bashir

Thrombolex receives enhanced indication for use from the FDA

The US Food and Drug Administration (FDA) has enhanced the indications for use of the Bashir endovascular catheter (Thrombolex) and the Bashir Plus endovascular...

Propofol use during catheter-directed interventions for intermediate-risk PE associated with major...

A study suggests avoiding propofol for intraprocedural sedation during catheter-directed interventions (CDIs) for intermediate-risk pulmonary embolism (PE) because it can have detrimental effects. Propofol...

AI triage solution for PE and aortic dissection receives FDA clearance...

Medical imaging artificial intelligence (AI) specialist Avicenna.AI recently announced that it has received certification in the USA and European Union (EU) for CINA CHEST,...

Aidoc and Imbio partner to provide an AI solution to prioritise...

Aidoc and Imbio have announced a partnership intended to provide an end-to-end artificial intelligence (AI) solution for pulmonary embolism (PE), with the goal of ultimately...

HOME-PE trial clarifies which patients with acute PE can be managed...

Patients with acute pulmonary embolism (PE) can be selected for home management using the sPESI score or the Hestia criteria, according to results of...

Study finds death rates from PE have been rising over the...

The American Heart Association (AHA) has announced that after nearly a decade of steady decline, the death rate for people with pulmonary embolism (PE)...
reduced hospital time and costs Xarelto

FDA mini-sentinel assessment confirms safety and effectiveness of Xarelto (rivaroxaban) amidst...

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced findings from the US Food and Drug Administration's (FDA) mini-sentinel assessment, confirming the positive...

First European advice on deep vein thrombosis published in European Heart...

The first comprehensive European advice on deep vein thrombosis was recently published in the European Heart Journal. The recommendations were produced by the European...
Venous News for specialists

GARFIELD-VTE Registry sheds light on global heterogeneity of venous thromboembolism patients,...

The first results from the GARFIELD-VTE (Global anticoagulant registry in the field—venous thromboembolism) were presented at the International Society on Thrombosis and Haemostasis Congress...

FDA grants priority review of Xarelto for a 10mg dose to...

The US Food and Drug Administration (FDA) has accepted, for priority review, a supplemental new drug application (sNDA) for Janssen’s Xarelto (rivaroxaban), to include...